OpenBilldrug price receipt

NADAC week of 2026-10-14

BUPRENORPHINE 8 MG TABLET SL

For 30 tablets

Pharmacies pay

$17.14 filed

30 × $0.57141 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$24.71 estimated

$17.14 + $2.57 (15%) + $5.00 fee per fill = $24.71

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

BUPRENORPHINE 8 MG TABLET SL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “buprenorphine”, “buprenorphine hcl” and “buprenorphine hydrochloride”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as tablet and its route as sublingual.

FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Hikma Pharmaceuticals USA Inc., PAI Holdings, LLC dba PAI Pharma and Actavis Pharma, Inc.

FDA’s Established Pharmacologic Class for it is Partial Opioid Agonist.

The NADAC file of 2026-10-14 prices it under 13 NDCs (National Drug Codes); the FDA directory lists 11 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $17.14 for 30 tablets (30 × $0.57141 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 11 labelers

LabelerNDCsPharmacies pay per unit
Actavis Pharma, Inc.1$0.57141 per EA filed
Advagen Pharma Ltd1$0.57141 per EA filed
American Health Packaging1$0.57141 per EA filed
AvPAK1$0.57141 per EA filed
Camber Pharmaceuticals, Inc.1$0.57141 per EA filed
Hikma Pharmaceuticals USA Inc.1$0.57141 per EA filed
Major Pharmaceuticals1$0.57141 per EA filed
PAI Holdings, LLC dba PAI Pharma1$0.57141 per EA filed
Rhodes Pharmaceuticals LLC1$0.57141 per EA filed
SpecGx LLC1$0.57141 per EA filed
Sun Pharmaceutical Industries, Inc.1$0.57141 per EA filed
Not listed as a package in the FDA directory2$0.57141 per EA filed
All 13 NDCs, with labeler and price
  • 00054-0177-13 · Hikma Pharmaceuticals USA Inc. · $0.57141 per EA · eff. 2026-09-23 filed
  • 00121-2038-30 · PAI Holdings, LLC dba PAI Pharma · $0.57141 per EA · eff. 2026-09-23 filed
  • 00228-3153-03 · Actavis Pharma, Inc. · $0.57141 per EA · eff. 2026-09-23 filed
  • 00406-7018-03 · SpecGx LLC · $0.57141 per EA · eff. 2026-09-23 filed
  • 00904-7155-04 · Major Pharmaceuticals · $0.57141 per EA · eff. 2026-09-23 filed
  • 31722-0871-30 · Camber Pharmaceuticals, Inc. · $0.57141 per EA · eff. 2026-09-23 filed
  • 42858-0502-03 · Rhodes Pharmaceuticals LLC · $0.57141 per EA · eff. 2026-09-23 filed
  • 50268-0129-11 · not listed as a package in the FDA directory · $0.57141 per EA · eff. 2026-09-23 filed
  • 50268-0129-15 · AvPAK · $0.57141 per EA · eff. 2026-09-23 filed
  • 60687-0492-11 · not listed as a package in the FDA directory · $0.57141 per EA · eff. 2026-09-23 filed
  • 60687-0492-21 · American Health Packaging · $0.57141 per EA · eff. 2026-09-23 filed
  • 62756-0460-83 · Sun Pharmaceutical Industries, Inc. · $0.57141 per EA · eff. 2026-09-23 filed
  • 72888-0183-30 · Advagen Pharma Ltd · $0.57141 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

18 other products in the NADAC file share an FDA nonproprietary name with BUPRENORPHINE 8 MG TABLET SL.

ProductPharmacies pay per unitMedicare per unit
BELBUCA 75 MCG FILM
brand · film, soluble
$7.54173 per EA filed
eff. 2026-09-23
$12.76277 per EA filed
Part D 2024 average
BELBUCA 150 MCG FILM
brand · film, soluble
$7.55761 per EA filed
eff. 2026-09-23
$12.76277 per EA filed
Part D 2024 average
BELBUCA 300 MCG FILM
brand · film, soluble
$11.85628 per EA filed
eff. 2026-09-23
$12.76277 per EA filed
Part D 2024 average
BELBUCA 450 MCG FILM
brand · film, soluble
$16.1142 per EA filed
eff. 2026-09-23
$12.76277 per EA filed
Part D 2024 average
BELBUCA 600 MCG FILM
brand · film, soluble
$17.19033 per EA filed
eff. 2026-09-23
$12.76277 per EA filed
Part D 2024 average
BELBUCA 750 MCG FILM
brand · film, soluble
$18.09899 per EA filed
eff. 2026-09-23
$12.76277 per EA filed
Part D 2024 average
BELBUCA 900 MCG FILM
brand · film, soluble
$18.59055 per EA filed
eff. 2026-09-23
$12.76277 per EA filed
Part D 2024 average
BUPRENORPHINE 2 MG TABLET SL
generic · tablet
$0.27676 per EA filed
eff. 2026-09-23
We don’t know yet
BUPRENORPHINE 5 MCG/HR PATCH
generic · patch, extended release / patch
$23.44849 per EA filed
eff. 2026-09-23
$61.65324 per EA filed
Part D 2024 average
BUPRENORPHINE 7.5 MCG/HR PATCH
generic · patch, extended release / patch
$37.67882 per EA filed
eff. 2026-09-23
$61.65324 per EA filed
Part D 2024 average
BUPRENORPHINE 8 MG TABLET SL this page
generic · tablet
$0.57141 per EA filed
eff. 2026-09-23
We don’t know yet
BUPRENORPHINE 10 MCG/HR PATCH
generic · patch, extended release / patch
$32.52934 per EA filed
eff. 2026-09-23
$61.65324 per EA filed
Part D 2024 average
BUPRENORPHINE 15 MCG/HR PATCH
generic · patch, extended release / patch
$53.7821 per EA filed
eff. 2026-09-23
$61.65324 per EA filed
Part D 2024 average
BUPRENORPHINE 20 MCG/HR PATCH
generic · patch, extended release / patch
$58.8288 per EA filed
eff. 2026-09-23
$61.65324 per EA filed
Part D 2024 average
BUTRANS 5 MCG/HR PATCH
brand · patch, extended release
$48.86594 per EA filed
eff. 2026-09-23
$102.43317 per EA filed
Part D 2024 average
BUTRANS 7.5 MCG/HR PATCH
brand · patch, extended release
$68.82197 per EA filed
eff. 2026-09-23
$102.43317 per EA filed
Part D 2024 average
BUTRANS 10 MCG/HR PATCH
brand · patch, extended release
$73.60023 per EA filed
eff. 2026-09-23
$102.43317 per EA filed
Part D 2024 average
BUTRANS 15 MCG/HR PATCH
brand · patch, extended release
$124.62313 per EA filed
eff. 2026-09-23
$102.43317 per EA filed
Part D 2024 average
BUTRANS 20 MCG/HR PATCH
brand · patch, extended release
$131.09389 per EA filed
eff. 2026-09-23
$102.43317 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 13 NDCs’ NADAC prices is $0.57141 per EA filed.

Of the 34 other products in FDA’s Partial Opioid Agonist class priced per EA, 32 have a higher middle NADAC price and 2 a lower one. The one in the middle is BELBUCA 300 MCG FILM, at $11.85628 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 30 tablets?
NADAC prices this product per EA, and the FDA NDC Directory lists 11 of its 13 NDCs (it does not list the other 2) as a tablet taken under the tongue (dosage form “TABLET”, route “SUBLINGUAL”), so one EA is one tablet. OpenBill counts a tablet or film taken under the tongue or against the cheek as an oral solid, like one that is swallowed. The card starts at 30 tablets, a common one-month supply of a once-a-day medicine; change it to match your prescription.